$94.630
+1.893 (+2.00%)At close
MDT News
MDT Events
Medtronic Shares Rise $1.71 to $94.47
Moderately bullish activity in Medtronic (MDT), with shares up $1.71, or 1.84%, near $94.47. Options volume relatively light with 6476 contracts traded and calls leading puts for a put/call ratio of 0.82, compared to a typical level near 0.94. Implied volatility (IV30) is higher by 0.6 points near 24.29,and below the 52wk median, suggesting an expected daily move of $1.45. Put-call skew steepened, indicating increased demand for downside protection.
Medtronic Shares Up 0.51% to $92.39
Moderately bullish activity in Medtronic (MDT), with shares up 46c, or 0.51%, near $92.39. Options volume relatively light with 30k contracts traded and calls leading puts for a put/call ratio of 0.69, compared to a typical level near 0.86. Implied volatility (IV30) is higher by 0.1 points near 26.16,and above the 52wk median, suggesting an expected daily move of $1.52. Put-call skew flattened, suggesting a modestly bullish tone.
Notable Stock Gains for Medtronic and Others
Notable gainers among liquid option names this morning include Medtronic (MDT) $92.33 +3.84, Meta Platforms Inc (META) $746.15 +27.48, First Solar (FSLR) $184.45 +6.63, Biogen (BIIB) $232.73 +7.02, and Accenture (ACN) $215.31 +6.25.
Medtronic Announces Oversubscribed MiniMed Stock Exchange
Medtronic (MDT) announced that, based on preliminary results, its previously announced offer to exchange shares of common stock of MiniMed Group (MMED) for outstanding Medtronic ordinary shares was oversubscribed. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on October 9. Medtronic has decided to exchange all of its remaining interest in MiniMed, totaling 252,813,348 shares of MiniMed common stock. Under the terms of the exchange offer, 4.5939 shares of MiniMed common stock will be exchanged for each Medtronic ordinary share accepted in the exchange offer.
AMA Approves New CPT Codes for Medtronic
Medtronic announced that the American Medical Association approved new Category I Current Procedural Terminology - CPT - codes for two of its technologies: Altaviva implantable tibial neuromodulation device for the treatment of urge urinary incontinence and Symplicity Spyral renal denervation system for the treatment of uncontrolled hypertension. The new codes, which will replace existing Category III codes, are effective January 2028. Category I CPT codes are permanent codes assigned to procedures the AMA has determined are well established, widely performed by physicians across the U.S., and supported by clinical evidence, in addition to other criteria identified in the application process. A Category I CPT does not determine coverage, reimbursement, clinical superiority, or patient access.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.